Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
QTTB compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
QTTB
Q32 Bio Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
QTTB
Q32 Bio Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
QTTB: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only QTTB
6
BMY
Bristol-Myers Squibb Company ("BMS")
supplier
AKBA
Akebia Therapeutics, Inc. ("Akebia")
customer
—
The Regents of the University of Colorado ("Colorado")
unlisted
supplier
—
Horizon Therapeutics Ireland DAC
unlisted
supplier
2 more · QTTB chain
›
Shared
0
No shared counterparties.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
25 more · LLY chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
QTTB, solid
LLY, dashed
QTTB
Q32 Bio Inc.
Change
8.74
· pre 8.93
· delayed
Mkt cap
$260.8M
Revenue
$54M
Q4 FY25
Revenue
—
LLY
ELI Lilly & Co
Change
1,417.89
· pre 1,432.30
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
QTTB
Q32 Bio Inc.
vs
LLY
ELI Lilly & Co
8.74
pre 8.93
delayed
Price
1,417.89
pre 1,432.30
delayed
$260.8M
Mkt cap
$1.3T
Q4 FY25
$54M
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
QTTB
8.74
vs
LLY
1,417.89
Pre-market
Nov 5 '26
delayed